SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Crucell N.V. (CRXL) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (138)12/16/2003 10:53:27 AM
From: keokalani'nui  Respond to of 560
 
>>Still, they do seem to be firing on at least a couple of cylinders now...<<

Yes. It was a surefire 2004 contest entry for me before the run-up. Might still be. HIV, Malaria, flu outlicense being the potentially big drivers next year. First time I've felt really comfortable with my personal position since JnJ gave back the Mab.



To: nigel bates who wrote (138)12/18/2003 11:09:04 AM
From: keokalani'nui  Read Replies (1) | Respond to of 560
 
I don't assume you would get the chance to ask the company a direct question, but I've been wondering what is the change of control situation in the AMEV license(s) with Lilly soon to take them over. I hope Lilly is paying close attention to that itself, meaning I hope it wants very much to continue the production platform. If you hear anything, get the chance...

...maybe when I am in Italy I can briefly stop by corporate HQ.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News